About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Opium
- Procedure number
- PSUSA/00010670/201909
- Regulatory outcome
- Variation
Documents
Opium: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010670/201909
English (EN) (51.75 KB - PDF)
български (BG) (185.71 KB - PDF)
español (ES) (179.9 KB - PDF)
čeština (CS) (186.65 KB - PDF)
dansk (DA) (171.84 KB - PDF)
Deutsch (DE) (173.3 KB - PDF)
eesti keel (ET) (175.76 KB - PDF)
ελληνικά (EL) (185.52 KB - PDF)
français (FR) (313.69 KB - PDF)
hrvatski (HR) (182.64 KB - PDF)
íslenska (IS) (173.62 KB - PDF)
italiano (IT) (248.27 KB - PDF)
latviešu valoda (LV) (66.66 KB - PDF)
lietuvių kalba (LT) (183.75 KB - PDF)
magyar (HU) (184.75 KB - PDF)
Malti (MT) (282.14 KB - PDF)
Nederlands (NL) (170.74 KB - PDF)
norsk (NO) (201.6 KB - PDF)
polski (PL) (186.25 KB - PDF)
português (PT) (180.3 KB - PDF)
română (RO) (181.82 KB - PDF)
slovenčina (SK) (186.48 KB - PDF)
slovenščina (SL) (179.82 KB - PDF)
Suomi (FI) (69.45 KB - PDF)
svenska (SV) (69.86 KB - PDF)